10.01.2011 • News

Smith & Nephew Rejects $11 Billion Bid from Johnson & Johnson

British medical equipment company Smith & Nephew rejected a 7 billion pound ($10.9 billion) takeover approach from U.S. rival Johnson & Johnson late last year, Sky News said, without citing sources.

Sky said Johnson & Johnson (J&J) was considering whether to return with a higher offer, after its indicative bid of more than 750 pence a share was turned down as too low.

No one at Smith & Nephew (S&N), which is regularly tipped as a bid target for U.S. rivals such as privately owned Biomet, was immediately available for a comment. Bill Price, a J&J spokesman, said the company as a matter of policy does not comment on "rumors and speculation."

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.